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Little is known about the mechanism(s) underlying
hyperpigmentation in lentigo senilis. We have previ-
ously reported that keratinocyte-derived endothelins
are intrinsic paracrine mitogens and melanogens for
human melanocytes and that they play an essential
role in stimulating ultraviolet-B-induced melanogen-
esis. In this study, we have used immunohistochem-
istry and reverse transcriptase polymerase chain
reaction analysis to clarify the role of the endothelin
cascade, including endothelin production, processing
by endothelin-converting enzyme, and expression of
the endothelin B receptor, in the hyperpigmentary
mechanism(s) involved in lentigo senilis. The num-
ber of tyrosinase immunopositive melanocytes in
lentigo senilis lesional skin was increased 2-fold over
the perilesional epidermis. Immunohistochemistry
using antibodies to endothelin-1 demonstrated rela-
tively stronger staining in the lesional epidermis than
in the perilesional epidermis. Reverse transcriptase
polymerase chain reaction analysis concomitantly
demonstrated accentuated expression of transcripts
for endothelin-1 and for the endothelin B receptor in
lentigo senilis lesional skin, which was accompanied
by a similar accentuated expression of tyrosinase
mRNA compared with the perilesional control. The
endothelin-1-inducible cytokine, tumor necrosis fac-
tor a, was consistently upregulated in the lentigo
senilis lesional epidermis as determined at the tran-
scriptional level and by immunostaining, whereas
interleukin-1a was downregulated. In contrast,
endothelin-converting enzyme 1a mRNA was not
substantially increased in the lesional epidermis.
These ®ndings suggest that an accentuation of the
epidermal endothelin cascade, especially with respect
to expression of endothelin and the endothelin B
receptor, plays an important role in the mechanism
involved in the hyperpigmentation of lentigo senilis.
Keywords: endothelin B receptor/interleukin-1a/tumor
necrosis factor a. J Invest Dermatol 116:571±577, 2001
L
ittle is known about biologic mechanisms by which
melanocytes are activated to produce excessive amounts
of melanin in various hyperpigmentary disorders.
Recent evidence has suggested that melanocyte function
is regulated by several cytokines that are secreted by
surrounding epidermal cells (keratinocytes) in a paracrine fashion.
In ultraviolet B (UVB) induced pigmentation, human keratinocytes
exposed to UVB are stimulated to produce and secrete vasocon-
strictive peptides, termed endothelins (ETs), which trigger the
activation of melanocytes and act as potent mitogens and
melanogens for human melanocytes (Yada et al, 1991; Imokawa
et al, 1992, 1995, 1996a, 1997). Similarly, UVA-induced
pigmentation has been shown to be mediated by the action of
another mitogen for human melanocytes, termed granulocyte/
macrophage colony-stimulating factor (Imokawa et al, 1996b). In
allergic-contact-dermatitis-induced hyperpigmentation, we have
recently found that chemokines, such as growth-related oncogene
a, are produced and secreted by epidermal cells under allergic
in¯ammatory conditions, which results in the stimulation of
melanocytes (Imokawa et al, 1998). No information is available
regarding cytokines essential for stimulating melanization of
melanocytes in unstimulated epidermal hyperpigmentary disorders,
however.
Lentigo senilis (LS) is the skin condition of common aging
spots with accentuated epidermal pigmentation. Based upon the
observation that large numbers of melanin-producing melano-
cytes are located in the vicinity of highly proliferating
keratinocytes, as seen in hair follicles, we hypothesized that
the proliferating keratinocytes in LS trigger the activation of
neighboring melanocytes by secreting melanocyte-stimulating
cytokines. As, among the known keratinocyte-derived cytokines
produced in response to their proliferation, ET-1 is the only
cytokine that has dual stimulatory effects on DNA synthesis and
melanization of human melanocytes (Yada et al, 1991; Imokawa
et al, 1996a, 1997), it is of considerable interest to clarify
whether ET production and secretion is accentuated in the
epidermis of LS. Further, ET secretion is known to be
regulated by endothelin-converting enzyme (ECE-1a), which
converts the propeptide, big-ET, to its active form, ET-1 (Xu
et al, 1994). In addition to ET produced and secreted by
keratinocytes, ET action on melanocytes is mediated via the
endothelin B receptor (ETBR), which is a G-protein-coupled
transmembrane receptor (Tada et al, 1998). In this study,
therefore, we used immunohistochemistry and reverse tran-
scriptase polymerase chain reaction (RT-PCR) analysis to
determine whether the epidermal ET cascade, consisting of
ET production, ECE-1a (Xu et al, 1994), ET secretion, and
ETBR-mediated signaling (Brand et al, 1998; Imokawa et al,
2000), is accentuated in the LS epidermis.
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MATERIALS AND METHODS
Materials Normal human endothelial cells, ®broblasts, keratinocytes,
and E300 medium were obtained from Kyokuto (Tokyo, Japan). Serum-
free keratinocyte medium (SFM), bovine pituitary extract (BPE),
epidermal growth factor (EGF), and Dulbecco's modi®ed Eagle's
medium (DMEM) were purchased from Gibco Laboratories. Normal
human melanocytes and serum-free melanocyte medium (MGM) were
purchased from Sankou Pure Chemicals (Tokyo, Japan). Other chemicals
were of reagent grade.
Cell culture Cells were maintained at 37°C with 5% CO2. Human
endothelial cells, ®broblasts, keratinocytes, and melanocytes were
maintained in E300 medium, DMEM containing 10% fetal bovine
serum, modi®ed SFM supplemented with 5 ng per ml EGF and 50 mg
per ml BPE, and MGM supplemented with 1 ng per ml recombinant
basic ®broblast growth factor, 5 mg per ml insulin, 0.5 mg per ml
hydrocortisone, 10 ng per ml phorbol 12-myristate 13-acetate, antibiotics
(50 mg per ml streptomycin), and 0.2% (vol/vol) BPE, respectively.
Chemicals Streptavidin-biotin immunoperoxidase staining systems
were obtained from Shandon-Lipshaw (PA).
Antibodies Polyclonal antibodies against recombinant human ET-1,
tyrosinase, interleukin-1a (IL-1a), and tumor necrosis factor a (TNFa)
were purchased from Immuno Biological Laboratories (Gunma, Japan).
Samples Skin biopsy specimens were obtained from patients with LS
(n = 19; Japanese, six males, 13 females) and perilesional skin was
considered as nonlesional normal skin. These patients ranged in age from
45 to 80 y old (average, 62 y). The sites of skin excisions were in the
abdomen, lower legs, buttocks, and back, which are generally sun-
protected skin areas, and there were no symptoms of sun exposure when
the biopsies were taken. The main portion of each specimen was
subjected to routine histopathologic examination. Additional sample
specimens were embedded in Tissue-Tek OCT compound (Miles, IN),
snap-frozen in liquid nitrogen, and then stored at ±80°C until use.
Immunohistochemistry Cryostat sections (4 mm thick) were air-
dried, ®xed in cold acetone, and, after washing in 0.01 M
phosphate-buffered saline (PBS), incubated in 3% H2O2 for 5 min at
room temperature. After further washing in 0.01 M PBS, the sections
were incubated with protein blocking agent for 20 min at room
temperature. The sections were then washed again in 0.01 M PBS
and incubated overnight at 4°C in 0.01 M PBS, pH 7.2, with
antibodies to ET-1, TNFa, or IL-1a (1:50). After further washing in
0.01 M PBS, the sections were incubated for 30 min at room
temperature with rabbit IgG antibody, washed again in 0.01 M PBS,
and incubated for 30 min at room temperature with standard
Omnitags streptavidin-peroxidase. The reaction was then developed
with aminoethylcarbazole (AEC). Sections were incubated for 10±
15 min at room temperature with Omnitags plus/HRP kit (consisting
of two drops of sodium acetate buffer, two drops of AEC
chromogen concentrate, and two drops of 3% H2O2 in distilled
water), washed in PBS, and stained with hematoxylin and eosin.
Table I. Nucleotide sequences for 5¢ and 3¢ primers
Endothelin-1
3¢ primer 5¢-GACAGGCCCCGAAGTCTGTCA-3¢
Tyrosinase
5¢ primer 5¢-TATGAATGGAACAATGTCCCAGGT-3¢
3¢ primer 5¢-ATGACCAGATCCGACTCGCTTG-3¢
ETBR
5¢ primer 5¢-CGAGCTGTTGCTTCTTGGAGTAG-3¢
3¢ primer 5¢-AACGGAAGTTGTCATATCCGTGAT-3¢
ECE-1a
5¢ primer 5¢-CGCTGGGGATGTCGACGTACAA-3¢
3¢ primer 5¢-GGGGTCCACTGTGGGGTCCAT-3¢
IL-1a
5¢ primer 5¢-TTGAAGACCTGAAGAACTGTTACAG-3¢
3¢ primer 5¢-TAAAGTTGTATTTCACATTGCTCAGGA-3¢
TNFa
5¢ primer 5¢-GAGTGACAAGCCTGTAGCCCATGTTGTAGCA-3¢
3¢ primer 5¢-GCAATGATCCCATTGTAGACCTCCCAGACT-3¢
GAPDH
5¢ primer 5¢-GAAGGTGAAGGTCGGAGTCAACG-3¢
3¢ primer 5¢-AGTCCTTCCACGATACCAAAGTTG-3¢
Figure 1. The expression of ETBR mRNA in various cultured
human skin cells.
Figure 2. Immunohistochemistry with tyrosinase antibodies in
the epidermis of LS. (A) Lesional skin (1803); (B) non-lesional skin
(1803).
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Detection of ECE-1a, ET-1, ETBR, and tyrosinase gene transcripts
in cultured cells or human epidermis from LS and perilesional
normal skin Biopsy specimens were obtained from LS and perilesional
skin as detailed above. The epidermal sheet of each specimen was
separated by heating for 3±4 min at 60°C. The residue of separated tissue
was examined after periodic acid-Schiff staining and we con®rmed that
the separation took place within the epidermis, leaving no dermal
components on the epidermal sheet. Total cellular RNA was extracted
from cultured human keratinocytes, endothelial cells, ®broblasts, and
melanocytes, or from the separated epidermis, using acid guanidinium
phenol chloroform with only a single precipitation. The RNA was
quanti®ed by measuring the optical density at 260 nm. About 1 mg of
total RNA was obtained from each tissue sample. To synthesize oligo-
(dT16)-primed cDNA, total RNA was heated to 65°C for 3 min, and
then chilled on ice. Reverse transcription was performed in 20 ml
reaction mixtures containing 2 ml 10 3 PCR buffer II, 4 ml MgCl2
(25 mM), 1 ml oligo-(dT16) (50 mM), 8 ml deoxynucleotides (2.5 mM
each), 1 ml RNase inhibitor (20 U per ml), 1 ml Moloney murine
leukemia virus reverse transcriptase (50 U per ml), and 3 ml RNA
Figure 3. The increased number of tyrosinase immunopositive
melanocytes in the epidermis of LS.
Figure 4. RT-PCR analysis of ET-1 mRNA in the epidermis of
LS and in perilesional skin. (A) Fluorogram; (B) densitometric
analysis. NL, non-lesional epidermis; L, lesional epidermis of LS.
Fluorograms are shown at 35 or 37 cycles of PCR for ET-1 and at 22 or
23 cycles for GAPDH. *p < 0.05.
Figure 5. RT-PCR analysis of tyrosinase mRNA in the epidermis
of LS and in perilesional skin. (A) Fluorogram; (B) densitometric
analysis. NL, non-lesional epidermis; L, lesional epidermis of LS.
Fluorograms are shown at 31 or 35 cycles of PCR for tyrosinase and at
23 or 25 cycles for GAPDH. ***p < 0.005.
Figure 6. RT-PCR analysis of ECE-1a mRNA in the epidermis
of LS and in perilesional skin. (A) Fluorogram; (B) densitometric
analysis. NL, non-lesional epidermis; L, lesional epidermis of LS. *p
< 0.05.
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(300 ng in DEPC-treated water). Reaction mixtures were incubated at
42°C for 60 min and 52°C for 30 min, and then heated to 99°C for
5 min to inactivate the reverse transcriptase. For PCR ampli®cation, 2 ml
of the cDNA reaction mixture was added to 8 ml of an 80 ml PCR
mixture containing 4 ml MgCl2 (25 mM), 8 ml 10 3 PCR buffer II,
1 ml each of the 3¢ and 5¢ primers (20 mM each), and 0.5 ml Taq
polymerase (Cetus). Reaction mixtures were overlaid with mineral oil,
and then ampli®ed using a Perkin-Elmer/Cetus thermal cycler. The
PCR cycle conditions were melting for 1 min at 95°C, annealing for
1 min at 60°C, and extension for 2 min at 72°C. Reaction products
(5 ml) were resolved on 1%±1.5% agarose gels and were visualized by
ethidium bromide staining. Primers for ET-1, tyrosinase, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were synthesized
on a DNA synthesizer (Applied Bio Systems). The sequences of the 3¢
and 5¢ primer pairs used in this study are shown in Table I. As negative
controls, we conducted PCR without reverse transcriptase and
con®rmed that there was no ampli®cation of the transcripts. To
quantitate the expression of the transcripts, the intensities of PCR bands
were measured by densitometry and are expressed as intensities relative
to GAPDH.
Statistics The level of signi®cance of the difference was calculated by
the Student t test.
RESULTS
ETBR gene expression in human keratinocytes and
melanocytes To examine whether the ETBR gene is
exclusively expressed by human melanocytes among the various
types of epidermal cells, we used RT-PCR to compare the levels of
expression of that gene by human keratinocytes, melanocytes,
®broblasts, and endothelial cells in culture. RT-PCR analysis of
ETBR mRNA demonstrated its distinct or slight expression by
human melanocytes or endothelial cells, respectively, but not by
human keratinocytes and human ®broblasts (Fig 1).
Melanocyte population To determine whether the epidermal
hyperpigmentation of LS is associated with an increased
proliferation of melanocytes, we ®rst studied the population of
melanocytes by measuring their number following immunostaining
with a tyrosinase antibody. The immunostaining revealed
immunoreactivity localized to a few dendritic cells along the
basal layer (Fig 2), suggesting an increased proliferation of
melanocytes in the LS epidermis. Quantitation along the interface
between the epidermis and the dermis revealed that the number of
tyrosinase immunopositive melanocytes was increased 2-fold in the
lesional LS epidermis compared with the perilesional epidermis
(Fig 3).
ET-1, ECE-1a, IL-1a, TNFa, and ETBR gene transcripts in
LS To examine whether the increased melanogenesis was
associated with accentuation of the ET cascade in LS, we
examined expression of the ECE-1a, ET-1, and ETBR genes
using RT-PCR. Analysis of ET-1 mRNA demonstrated an
increased expression (average 3.6-fold, n = 6) of the ET-1
transcript in LS skin compared with that in perilesional normal
skin (Fig 4) and there was also a marked increase (average 2.3-fold,
n = 7) in tyrosinase transcripts in the lesional LS skin (Fig 5). As
the production of ET-1 is biologically regulated by ECE-1a (Xu et
al, 1994), we determined whether the ECE-1a transcript was also
upregulated in LS, which would result in the increased secretion of
ET-1. RT-PCR analysis of ECE-1a mRNA, however, revealed
no substantial difference in expression (average 1.3-fold, n = 4) of
the ECE-1a transcript in the lesional LS skin (Fig 6). As IL-1a and
TNFa are known as ET-1-inducible cytokines in cultured human
keratinocytes (Imokawa et al, 1992; Tsuboi et al, 1994), we also
examined the expression of IL-1a (n = 2) and TNFa mRNA
(n = 3) in the LS epidermis. RT-PCR of these mRNAs
demonstrated a decrease (average 3.8-fold, n = 2) and an increase
(average 5.5-fold, n = 3) in the expression of IL-1a and TNFa,
respectively, in the lesional LS epidermis (Figs 7, 8), suggesting the
involvement of TNFa as a primary cytokine in the accentuated
production of ET.
In human melanocytes, ET-1 secreted by keratinocytes
triggers the activation of the intracellular protein kinase C
dependent signaling pathway through ETBRs (Imokawa et al,
2000). Therefore, we determined whether the expression of
ETBRs was also accentuated in melanocytes in the LS
Figure 7. RT-PCR analysis of IL-1a in the epidermis of LS and
in perilesional skin. (A) Fluorogram; (B) densitometric analysis. NL,
non-lesional epidermis; L, lesional epidermis of LS.
Figure 8. RT-PCR analysis of TNFa mRNA in the epidermis of
LS and in perilesional skin. (A) Fluorogram; (B) densitometric
analysis. NL, non-lesional epidermis; L, lesional epidermis of LS. *p
< 0.05.
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epidermis. RT-PCR of ETBR mRNA revealed an increased
expression (average 6.8-fold, n = 7) of ETBR transcripts
(Fig 9), suggesting the coordinated increase in expression of
the ET-1/ETBR linkage. To examine whether there were
variations in the patterns of expression of the transcripts tested,
we compared the expression of ET-1, ECE-1a, tyrosinase,
ETBR, IL-1a, and TNFa transcripts in the epidermis of the
same donor with LS. RT-PCR analysis of these mRNAs
revealed a reproducible expression pattern for each transcript
that was similar to the above results (Fig 10). The ET-1,
tyrosinase, ETBR, and TNFa transcripts were upregulated,
whereas the IL-1a transcript was downregulated, in the
epidermis of LS relative to the perilesional normal epidermis.
On the other hand, there was no substantial difference in the
expression of ECE-1a transcript between LS and the perile-
sional skin.
Immunohistochemistry To con®rm the upregulated
production of ET-1 in LS, we examined whether the production
of this cytokine in LS actually re¯ected the changes observed in
their transcript levels. Staining with antibodies against ET-1
revealed a distinct positive immunoreactivity throughout the
basal layers and along the lower epidermis in LS (Fig 11),
whereas there was only a weakly positive staining in the
perilesional normal control. As IL-1a and TNFa are known to
stimulate the secretion of ET-1 in cultured human keratinocytes
(Imokawa et al, 1992; Tsuboi et al, 1994), we also evaluated the
levels of IL-1a and TNFa by immunohistochemistry. Staining
with antibodies against TNFa revealed a positive immunoreactivity
throughout the LS epidermis (Fig 12), whereas there was only a
weakly positive staining in the perilesional normal control. In
contrast, staining with IL-1a antibodies was decreased in LS
relative to the perilesional skin (Fig 13).
DISCUSSION
LS is a skin condition comprising slightly hyperplastic pigmented
spots, which appear over the entire body, especially on sun-exposed
areas. The clinical features of LS are distinct from those of UVB-
induced pigmentation, the latter being strictly localized in UVB-
irradiated areas and generally accompanied by cutaneous in¯am-
mation (Imokawa et al, 1992). Therefore, the pathogenesis of LS is
poorly characterized, particularly with respect to the mechanism
involved in the hyperpigmentation. Because of the potential role of
ET as a paracrine cytokine in the activation of epidermal
Figure 9. RT-PCR analysis of ETBR mRNA in the epidermis of
LS and in perilesional skin. (A) Fluorogram; (B) densitometric
analysis. NL, non-lesional epidermis; L, lesional epidermis of LS.
Fluorograms are shown at 34 or 37 cycles of PCR for ETBR and at 22
or 25 cycles for GAPDH. *p < 0.05.
Figure 10. RT-PCR analysis of all transcripts used in the
epidermis of the same donor with LS and the perilesional skin.
NL, non-lesional epidermis; L, lesional epidermis of LS.
Figure 11. Immunostaining with anti-ET-1 in the epidermis of
LS. (A) Lesion (1803); (B) non-lesion (1803).
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melanocytes, as occurs in UVB pigmentation (Imokawa et al, 1992,
1995), it is of particular interest to clarify the potential involvement
of the ET cascade in the hyperpigmentation associated with LS.
Although ET plays an essential role in activating melanocyte
function following stimulation such as in UVB-exposed skin where
ET is overproduced by irradiated keratinocytes (Imokawa et al,
1992), this study has provided a new insight into the role of ET as a
regulator of human melanocytes in the epidermal hyperpigmenta-
tion involved in a variety of pigmentary disorders. The potential of
keratinocytes located in the LS lesional epidermis to produce ET-1
was signi®cantly higher than in the perilesional normal controls.
The increased production and localization of ET-1, as assessed in
LS epidermis by immunostaining, were paralleled by increased
amounts of tyrosinase in melanocytes revealed by immunostaining
with tyrosinase antibody. This suggests that melanocyte activation,
including their stimulated proliferation and increased production of
tyrosinase, occurs in LS lesional skin concomitant with the
stimulation of ET-1 production by surrounding keratinocytes.
Consistent with these immunohistochemical observations, RT-
PCR analysis of mRNAs isolated from the epidermis of lesional LS
skin revealed that, whereas ET-1 and tyrosinase mRNA signals are
weak in perilesional normal skin, there is a marked increase in the
expression of both genes in LS lesional epidermis. ET-1 is a potent
vasoconstrictive peptide that was discovered in the conditioned
medium of endothelial cells (Yanagisawa et al, 1988). Recently,
ET-1 has been de®ned as a strong mitogen and melanogen for
human melanocytes (Imokawa et al, 1996a, 1997). UVB exposure
stimulates autocrine production of ET-1 through IL-1a secretion
in keratinocytes, which in turn leads to the activation of
melanocyte function seen in UVB-induced hyperpigmentation
(Imokawa et al, 1995). Based on these ®ndings, the accentuated
production and expression of ET-1 and ET-1 mRNA, respectively,
in LS epidermis strongly suggests that the increased production of
ET-1 is a major factor responsible for the hyperpigmentation seen
in LS.
There is another regulatory factor involved in the secretion of
ET-1 by keratinocytes. ETs are synthesized in endothelial cells as a
36 amino acid prepropeptide (Yanagisawa et al, 1988), which is
subsequently converted by ECE-1a to its active form (Xu et al,
1994). Thus, production of the active form of ET depends on the
activity of ECE-1a, probably based on its level of expression in the
epidermis. RT-PCR analysis of ECE-1a previously demonstrated
that human keratinocytes in culture express the same ECE-1a
transcript as do endothelial cells and that its expression is not altered
by UVB exposure, in contrast to an increased expression of the ET-
1 transcript.1 This suggests that, as in endothelial cells, ECE-1a
plays an important role in the secretion of the active form of ET-1
by human keratinocytes and that UVB exposure does not trigger
increases in the expression of ECE-1a. RT-PCR analysis revealed
that the LS lesional epidermis has no substantial increase in the
expression of ECE-1a transcripts compared with the perilesional
control, which suggests no involvement of ECE-1a in the
stimulated secretion of ET-1 in the lesional skin.
There is yet another mechanism known to be involved in the
stimulation of ET-1 production in the epidermis. The cytokine IL-
1a is stimulated and released by keratinocytes following UVB
irradiation, which triggers the production of ET-1 by keratinocytes
in an autocrine fashion (Imokawa et al, 1992). The observation that
large numbers of melanin-producing melanocytes are localized in
Figure 12. Immunostaining with anti-TNFa in the epidermis of
LS. (A) Lesion (1803); (B) non-lesion (1803).
Figure 13. Immunostaining with anti-IL-1a in the epidermis of
LS. (A) Lesion (1803); (B) non-lesion (1803).
1Manaka I, Tajima S, Teraki E, Kawashima M, Miyagishi M, Imokawa
G: Role of endothelin-1 in hyperpigmentation in seborrheic keratosis.
Pigment Cell Res. Supplement 5:81 1998 (abstr.)
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the general vicinity of highly proliferating keratinocytes, as seen in
hair follicles or in seborrhoeic keratosis (Teraki et al, 1996), led us
to suppose that keratinocytes may secrete large amounts of IL-1a
during the slightly proliferative conditions of LS epidermis, which
might trigger the autocrine stimulation of ET-1 production.
Immunohistochemistry with IL-1a antibodies, however, unexpec-
tedly demonstrated downregulation of IL-1a in the LS lesional
epidermis compared with the perilesional epidermis. In contrast, a
similar ET-inducible cytokine, TNFa (Tsuboi et al, 1994), is
expressed at high levels in the lesional LS epidermis relative to the
perilesional epidermis. The expression of transcripts encoding IL-
1a or TNFa was consistently downregulated or upregulated,
respectively, in the lesional LS epidermis. Thus it is likely that the
accentuated expression of ET-1 in LS epidermis is mediated via the
increased production of TNFa, although the speci®c mechanisms
involved in the high expression of TNFa remain unclear.
Because of the essential role of the ETBR in intracellular
signaling elicited by ET within melanocytes (Tada et al, 1998;
Imokawa et al, 2000), it is probable that expression of the ETBR on
melanocytes in the LS epidermis is also involved in the stimulation
by ET that leads to the accentuation of melanin production. In the
epidermis, it has been documented that keratinocytes also express
the ETBR (Tsuboi et al, 1994; Kelley et al, 1994). There is a
negligible expression of ETBR by cultured human keratinocytes,
however, in contrast to their marked expression by cultured human
melanocytes, whereas the in vitro expression of ETBR in phorbol-
ester-treated melanocytes may not necessarily re¯ect their in vivo
expression. In this connection, it should be noted that there is a
distinct immunostaining with polyclonal antibodies to ETBR in
melanocytes, but not in keratinocytes in the normal human
epidermis.2 Because the expression of ETBR mRNA in the
epidermis substantially re¯ects the production per epidermal cell
unit, the upregulated expression of the ETBR in the LS epidermis
suggests that the increased secretion of ET-1 and its receptor are
stimulated in a manner coordinated with epidermal hyperpigmen-
tation in LS. As the expression of the ETBR has also been shown to
be directly regulated by TNFa in human endothelial cells (Smith et
al, 1998), the increased expression of the ETBR may also result
from the upregulation of TNFa in LS.
In UVB-induced pigmentation, we have recently found that, in
addition to ET-1, membrane-bound stem cell factor (SCF) plays an
important role in stimulating the proliferation and melanogenesis of
melanocytes, and that this is accompanied by an increase in the
expression of the SCF receptor, c-kit.3 Further, we have recently
reported that there is a synergistic crosstalk between ET-1 and SCF
in the stimulation of mitogenesis and melanogenesis in human
melanocytes (Imokawa et al, 2000). Therefore, it will be of
considerable interest in the future to determine whether the SCF/
c-kit cascade is also upregulated in LS epidermis, which would
support the stimulatory effect of ET-1 on melanogenesis in LS in
concert with SCF.
In conclusion, ET-1 is the only keratinocyte-derived cytokine
reported to date that can stimulate both proliferation and
melanization of human melanocytes at concentrations as low as
1 nM (Yada et al, 1991; Imokawa et al, 1997). Thus, it seems likely
that the increased secretion of ET-1 noted in LS epidermis is the
major factor responsible for the hyperpigmentation found in this
pigmentary disorder. Taken together, our ®ndings suggest that
upregulation of the ET cascade, which consists of the production
and secretion of ET-1 by keratinocytes and the ET/ETBR binding-
mediated signal transduction pathway in melanocytes, plays an
important role in the stimulated pigmentation in LS.
We thank Ms. Minako Sakuma for her excellent technical assistance.
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